跳至主要内容
临床试验/CTRI/2014/12/005235
CTRI/2014/12/005235进行中(未招募)4 期

The reduction by acetyl salicylic acid of death rate due to acute coronary syndrome in patients with breast cancer.

Prof Asru K Sinha DSc0 个研究点目标入组 1,140 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
入组人数
1,140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Breast cancer was diagnosed by mammogram followed by biopsy carried out by professional pathologists.
  • 2. Patients were categorized by TNM (tumor size, no. of nodes & metastasis) classification at presentation.
  • 3. Patients willing to give consent and agreed to obtain judicial affidavit from the court of law and signed informed consent form were included in the study.

排除标准

  • 1. Institutionalized patients,
  • 2. History of diabetes mellitus,
  • 3. Systemic hypertension,
  • 4. Severe infections,
  • 5. Life-threatening cardiovascular diseases,
  • 6. Cerebrovascular conditions,
  • 7. Bundle branch block or left-ventricular hypertrophy as shown in EKG.

研究者

发起方
Prof Asru K Sinha DSc

相似试验